Japanese govt injects $115 M to enhance mRNA manufacturing
Vaccines | News | 0 Comment | 16 Aug, 2023
US-based Arcturus Therapeutics Holdings Inc., has announced that ARCALIS Co., its manufacturing joint venture in Japan t...Read more
First step towards new vaccine for childhood ear infections in Australia
Vaccines | News | 0 Comment | 09 Aug, 2023
Australia's University of Adelaide researchers have started work on developing a new vaccine that could help ward off pa...Read more
SK bioscience announces equity investment in Novavax to strengthen strategic partnership
Vaccines | News | 0 Comment | 09 Aug, 2023
South Korea-based SK bioscience, an innovative vaccine and biotech company, has decided to make an equity investment in ...Read more
Bio Farma and MSD launch human papillomavirus vaccine in Indonesia
Vaccines | News | 0 Comment | 04 Aug, 2023
Bio Farma Induk Holding BUMN Pharmacy, with its subsidiaries Kimia Farma and Indofarma, in collaboration with Merck Shar...Read more
Japan's Toyo Ink Group invests in US-based VLP Therapeutics to accelerate vaccine development
Vaccines | News | 0 Comment | 03 Aug, 2023
Toyo Ink SC Holdings, the parent company of Japan-based specialty chemicals manufacturer Toyo Ink Group, has concluded...Read more
Zuellig Pharma and GSK establish vaccine distribution hub in Singapore
Vaccines | News | 0 Comment | 01 Aug, 2023
Zuellig Pharma, one of the largest healthcare services groups in Asia, has entered into an agreement with global biophar...Read more
“Making mRNA vaccines in Asia can potentially bring more affordable vaccines to the world”
Vaccines | Opinion | 0 Comment | 02 Aug, 2023
What are the key opportunities and challenges for APAC vaccine manufacturers in adopting and utilising mRNA technology?&...Read more
Korea's GC Biopharma gets its first-ever approval of quadrivalent flu vaccine in Africa
Vaccines | News | 0 Comment | 24 Jul, 2023
GC Biopharma, a South Korean biopharmaceutical company, has announced that its quadrivalent flu vaccine called GC F...Read more
GSK expands its state-of-the-art vaccines facility in Singapore with a S$343 million investment
Vaccines | Company results | By Hithaishi C Bhaskar | 2 Comment | 13 Jul, 2023
GSK Singapore commemorated the groundbreaking ceremony for its S$343 million state-of-the-art vaccines facility at Tuas ...Read more
Sanofi to manufacture and supply vaccines in Saudi Arabia
Vaccines | News | 0 Comment | 06 Jul, 2023
Lifera, a biopharmaceutical company in Saudi Arabia together with French multinational pharmaceutical and healthcar...Read more
SK bioscience to transfer technology for strengthening vaccine manufacturing in Thailand
Vaccines | News | 0 Comment | 06 Jul, 2023
South Korea-based biotech firm SK bioscience has signed a Memorandum of Understanding (MoU) with the Government Pha...Read more
Japan approves updated indication for GSK's Shingrix vaccine
Vaccines | News | 0 Comment | 28 Jun, 2023
British firm GlaxoSmithKline (GSK) has announced that the Japanese Ministry of Health, Labour and Welfare (MHL...Read more
Korea's SK bioscience inks agreement on influenza research with Doherty Institute in Australia
Vaccines | News | 0 Comment | 28 Jun, 2023
SK bioscience, a global innovative vaccine and biotech company based in South Korea, has signed a collaboratio...Read more
International Vaccine Institute inks new agreement with Seoul National University
Vaccines | News | 0 Comment | 21 Jun, 2023
The International Vaccine Institute (IVI) and Seoul National University signed an agreement to expand collaboration in r...Read more
Vaxxas opens manufacturing facility in Australia to produce needle-free vaccine patch
Vaccines | News | 0 Comment | 19 Jun, 2023
Vaxxas, a clinical-stage biotechnology company commercialising a novel vaccination platform technology, has announced th...Read more
Korea-Africa establish new partnership for vaccine R&D and biomanufacturing training
Vaccines | News | 0 Comment | 14 Jun, 2023
South Korea-based International Vaccine Institute (IVI) and Institut Pasteur de Dakar (IPD) in West Africa, have signed ...Read more
mRNA technology a ‘Game Changer’ for Asia-Pacific vaccine manufacturers: Merck study
Vaccines | News | 0 Comment | 01 Jun, 2023
According to a recent study sponsored by Merck, a leading science and technology company, mRNA technology is a “ga...Read more
SK bioscience receives marketing authorisation of COVID-19 vaccine in UK
Vaccines | News | 0 Comment | 31 May, 2023
SK bioscience, based in South Korea, has announced the UK’s Medicines and Healthcare products Regulatory Agency (M...Read more